Cancer 101 is a comprehensive course consisting of 21 videos covering the fundamentals of oncology and onco-hematology, with lengths ranging from 5 to 30 minutes. The course is currently available in English, Portuguese and Spanish.
The course aims to:
Promote the development of a broader theoretical foundation among oncology and onco-hematology professionals in the pharmaceutical industry:
Enhance confidence in discussions with physicians
Improve the understanding and mastery of information directly related to the products
Facilitate the transition to working with other products that may become part of the company's portfolio
Provide permanent reference materials
Enable the rapid integration of additional colleagues who may join the company’s team
The learning objectives are:
To understand the pathophysiology of oncogenesis
To study the risk factors, prevention and screening of cancer
To discuss the imaging and anatomopathological diagnosis of cancer
To distinguish between prognostic and predictive factors
To review cancer treatments:
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Hormone therapy
Targeted therapies
Other treatment modalities
To address the sequencing of cancer treatments
To investigate the concepts of epidemiology
To dissect the anatomy of clinical studies, including:
Main characteristics and elements of clinical trials
Efficacy endpoints
Statistical analyses of clinical trials
Safety and tolerability
Quality of life
Scientific evidence
Interested? Watch the demo below and get in touch!
Cancer 101
Get in touch
2025 © FPMD Medical Affairs Ltd.